Literature DB >> 2390244

Adult vitelliform macular degeneration: a clinical spectrum.

A H Greaves1, J P Sarks, S H Sarks.   

Abstract

Adult vitelliform macular degeneration (adult Best's disease) has a spectrum of clinical appearances which may include focal macular pigment clumps as well as the more typical small, yellow lesions. We surveyed 81 patients with this diagnosis retrospectively. Ages ranged from 36 to 87 years, with an average age of 67 years. Males and females were almost equally represented. Median visual acuity at presentation was 6/12 for eyes with yellow lesions, and 6/9 for eyes with pigment clumps. Of 17 cases followed for an average of 3.6 years, there was a decrease in visual acuity of two lines or more in five cases. A significant proportion of patients also had other manifestations of age-related macular degeneration. Adult vitelliform macular degeneration probably falls within the spectrum of age-related macular degeneration.

Entities:  

Mesh:

Year:  1990        PMID: 2390244     DOI: 10.1111/j.1442-9071.1990.tb00610.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  5 in total

1.  Prevalence of reticular pseudodrusen in newly presenting adult onset foveomacular vitelliform dystrophy.

Authors:  C Wilde; A Lakshmanan; M Patel; M U Morales; S Dhar-Munshi; W M K Amoaku
Journal:  Eye (Lond)       Date:  2016-04-01       Impact factor: 3.775

2.  Macular translocation in a patient with adult-onset foveomacular vitelliform dystrophy with light- and electron-microscopic observations on the surgically removed subfoveal tissue.

Authors:  Claus Eckardt; Ute Eckardt; Stephanie Groos; Liliana Luciano; Enrico Reale
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-05-11       Impact factor: 3.117

3.  [Clinical diagnostic prerequisites for adult vitelliform macular dystrophy].

Authors:  A B Renner; H Tillack; H Kraus; U Kellner; M H Foerster
Journal:  Ophthalmologe       Date:  2004-09       Impact factor: 1.059

4.  Natural course of adult-onset vitelliform lesions in eyes with and without comorbid subretinal drusenoid deposits.

Authors:  Craig Wilde; Mary Awad; Konstantinos Giannouladis; Arun Lakshmanan; Aaron Ming-Hon Yeung; Harminder Dua; Winfried M K Amoaku
Journal:  Int Ophthalmol       Date:  2020-03-04       Impact factor: 2.031

5.  Acquired Vitelliform Macular Degeneration: Characteristics and Challenges of Managing Subretinal Fluid.

Authors:  Joseph Juliano; Sagar Patel; Hossein Ameri
Journal:  J Ophthalmic Vis Res       Date:  2021-10-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.